brexit

Showing 15 posts of 137 posts found.

brexit-referendum-uk-1468255193y2p

Brexit Health Alliance: Brexit and the impact on patient access to medicines

March 28, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Brexit Health Alliance, brexit, feature, market access, pharma

On behalf of the Brexit Health Alliance, Sarah Collen, Senior Policy Manager at NHS Confederation, details the potential negative fallout …

eu-flag-2108026_960_720

Six reasons why UK pharma has more to gain, than fear, from Brexit

March 26, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EMA, EU, biotech, brexit, drugs, hard Brexit, pharma, pharmaceutical

There are good reasons to think exiting the EU represents a major opportunity for this dynamic and world-leading industry, argues …

4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

March 23, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Canada, Celgene, Lundbeck, Marijuana, Novartis, Roche, Vertex, brexit, cannabis, multiple sclerosis, neuroscience, pharma

As me move startlingly quickly towards Easter, it’s time for another Top Ten rundown. This week, Celgene surprised the industry …

brexit_flag_0

Independent committee report seeks Brexit healthcare clarity

March 21, 2018
Medical Communications, Research and Development ABPI, UK, biotech, brexit, drugs, pharma, pharmaceutical

An independent report, entitled Brexit – Medicines, Medical Devices and Substances of Human Origin and written by the Health and …

pharmafocus_march_2018_cover

Pharmafocus March 2018 is available to read online now!

February 28, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Pharmafocus, brexit, drug safety, pharma, real world data

Though never truly out of vogue, the drug pricing debate has flared up again with the White House’s release of …

cambridge_biomedical_campus

Delivering the life sciences agenda: Easy as ABC

January 29, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Life sciences strategy, biotech, brexit, drugs, pharma, pharmaceutical

Andrew Blevins and Andrew Carrington of Liberty Property Trust and Countryside Properties explain how organisations at the Cambridge Biomedical Campus …

brexit_flag_0

Brexit Health Alliance warns of UK at back of the medicine queue

January 29, 2018
Medical Communications, Sales and Marketing biotech, brexit, drugs, pharma, pharmaceutical

The Brexit Health Alliance (BHA) has cautioned that unless a favourable deal is struck, the UK could end Brexit negotiations …

nicolas_raymond

The measurement underpinning government goals for UK life sciences

January 22, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Life Sciences Industrial Strategy, brexit, john bell, life sciences, pharma

Michael Adeogun, Head of Life Sciences and Health at National Physical Laboratory, discusses the importance of effective measurement for the …

1707_eu-agencies_relocations_website

EMA Headquarters: There’s no place like home

November 13, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EMA, biotech, brexit, drugs, pharma, pharmaceutical

With the result of the Brexit referendum, the future of the EMA’s London headquarters was cast in doubt. Now, 19 …

astrazeneca_logo_building

AstraZeneca Chairman wants three-year Brexit transition period

October 3, 2017
Manufacturing and Production, Medical Communications AstraZeneca, biotech, brexit, drugs, pharma, pharmaceutical

The Chairman of AstraZeneca, Leif Johansson, revealed in no uncertain terms that his company would like there to be a …

The Gateway to Local Adoption Series

Latest content